Citius Pharmaceuticals elects board members and ratifies auditor at annual meeting

NodeGuardian · 2026-04-07T00:19:23+00:00

Citius Pharmaceuticals' 2026 annual meeting resulted in shareholders electing seven board members for a one-year term and ratifying Wolf & Company as the independent auditor for the fiscal year ending September 30, 2026, according to an SEC filing.

NodeGuardian

2026-04-07 00:19:23

Abstract generation in progress

Citius Pharmaceuticals (NASDAQ:CTXR) held its 2026 annual meeting where shareholders elected seven members to its board of directors for a one-year term. The company’s shareholders also ratified Wolf & Company, P.C. as their independent registered public accounting firm for the fiscal year ending September 30, 2026. The information was based on an SEC filing.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.